Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 03 Jun 2025
For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer, the oral proteolysis-targeting chimera ER degrader, vepdegestrant, leads to significantly ...
Read Full NewsForget salary. The cities winning the physician satisfaction race are playing a completely different game.
The prevalence of type 2 diabetes is rising among US youth, and if we don’t address the real causes, we really will see a potentially unstoppable surge.
Current evidence supports the use of this botanical agent to promote skin health, but more research is needed to ascertain more varied and curative applications for this popular natural product.
CRISPR cures for sickle cell disease, gene therapy for hemophilia A, and expanding CAR T cell uses point to a new era of potentially curative, personalized treatments.
Dr Teresa Amaral reviews new uveal melanoma guidelines, focusing on AJCC 8th Edition staging, the Liverpool prognostic tool, and the essential role of BAP1 and PRAME expression.
The Red Cross on Saturday paid tribute to three volunteers who are believed to have died after contracting Ebola while handling bodies.
Americans coming back from the Democratic Republic of the Congo, Uganda or South Sudan now have a second entry point for returning to the United States, with the CDC on...
1.
Coffee, Tea Tied to Lower Risk of Head and Neck Cancer
2.
Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?
3.
COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment
4.
Testosterone recovery linked to overall survival in high-risk prostate cancer
5.
Combination therapy improves outcomes for advanced triple-negative breast cancer
1.
Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management
2.
How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?
3.
Uncovering the Causes of Thrombocytosis: A Journey to Improved Health
4.
Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study
5.
First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
3.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
4.
Thromboprophylaxis In Medical Settings- An Update
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge